Actionable news
All posts from Actionable news
Actionable news in CLLS: Cellectis SA,

Cellectis up 6% premarket on CEO's CNBC inteview

Cellectis (NASDAQ:CLLS) is up 6% premarket on increased volume on CEO Dr. Andre Choulika's interview on CNBC where he explained the advantages of his company's off-the-shelf cellular cancer therapies...